Aqr Capital Management LLC Nektar Therapeutics Transaction History

Aqr Capital Management LLC

$95.2 Billion
Q1 2025

A detailed history of Aqr Capital Management LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Aqr Capital Management LLC holds 3,640,851 shares of NKTR stock, worth $90.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,640,851

Previous 833,256 336.94%

Holding current value

$90.3 Million

Previous $774,000 219.77%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.66 - $1.19 $1.85 Million - $3.34 Million	2,807,595 Added 336.94%	3,640,851 $2.48 Million
Q4 2024 Feb 14, 2025	BUY	$0.9 - $1.45 $298,499 - $480,915	331,666 Added 66.12%	833,256 $774,000
Q3 2024 Nov 14, 2024	BUY	$1.11 - $1.48 $556,764 - $742,353	501,590 New	501,590 $652,000
Q1 2024 May 15, 2024	SELL	$0.49 - $0.96 $492,237 - $964,383	-1,004,566 Reduced 69.98%	430,983 $400,000
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.57 $936,900 - $1.27 Million	-2,230,715 Reduced 60.84%	1,435,549 $803,000
Q3 2023 Nov 14, 2023	BUY	$0.51 - $1.05 $430,768 - $886,876	844,644 Added 29.93%	3,666,264 $2.2 Million
Q2 2023 Aug 14, 2023	BUY	$0.53 - $1.03 $44,303 - $86,098	83,591 Added 3.05%	2,821,620 $1.64 Million
Q1 2023 May 15, 2023	BUY	$0.64 - $3.15 $1.47 Million - $7.23 Million	2,295,171 Added 518.26%	2,738,029 $1.92 Million
Q4 2022 Feb 14, 2023	BUY	$2.03 - $4.28 $450,696 - $950,237	222,018 Added 100.53%	442,858 $1 Million
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $847,406 - $1.43 Million	-278,752 Reduced 55.8%	220,840 $704,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $1.01 Million - $1.96 Million	317,435 Added 174.26%	499,592 $1.9 Million
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $757,773 - $2.5 Million	182,157 New	182,157 $982,000
Q3 2019 Nov 14, 2019	SELL	$16.91 - $36.27 $12.8 Million - $27.4 Million	-755,535 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$31.0 - $36.3 $14.7 Million - $17.2 Million	-474,557 Reduced 38.58%	755,535 $26 Million
Q1 2019 May 14, 2019	BUY	$31.58 - $46.35 $4.66 Million - $6.84 Million	147,523 Added 13.63%	1,230,092 $41 Million
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $22.3 Million - $41.4 Million	731,600 Added 208.45%	1,082,569 $35.6 Million
Q3 2018 Nov 15, 2018	BUY	$46.46 - $68.49 $9.81 Million - $14.5 Million	211,132 Added 150.98%	350,969 $21.4 Million
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $4.14 Million - $9.34 Million	-89,436 Reduced 39.01%	139,837 $6.83 Million
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $3.22 Million - $6.08 Million	56,034 Added 32.34%	229,273 $24.4 Million
Q4 2017 Feb 14, 2018	BUY	$23.02 - $60.5 $3.99 Million - $10.5 Million	173,239	173,239 $10.3 Million

Others Institutions Holding NKTR

# of Institutions

158

Shares Held

122M

Call Options Held

1.18M

Put Options Held

64.6K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $4.65B
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Nektar Therapeutics Transaction History